Canada markets closed

Clearside Biomedical, Inc. (CLSD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.3400+0.0800 (+6.35%)
At close: 04:00PM EDT
1.3099 -0.03 (-2.25%)
After hours: 07:56PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 100.13M
Enterprise Value 72.22M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)10.07
Price/Book (mrq)N/A
Enterprise Value/Revenue 8.78
Enterprise Value/EBITDA -3.13

Trading Information

Stock Price History

Beta (5Y Monthly) 2.33
52-Week Change 334.00%
S&P500 52-Week Change 322.36%
52 Week High 32.1200
52 Week Low 30.6500
50-Day Moving Average 31.4491
200-Day Moving Average 31.1500

Share Statistics

Avg Vol (3 month) 3366.6k
Avg Vol (10 day) 3242.54k
Shares Outstanding 574.72M
Implied Shares Outstanding 674.72M
Float 869.15M
% Held by Insiders 17.30%
% Held by Institutions 121.24%
Shares Short (Apr 15, 2024) 4265.28k
Short Ratio (Apr 15, 2024) 40.71
Short % of Float (Apr 15, 2024) 40.38%
Short % of Shares Outstanding (Apr 15, 2024) 40.36%
Shares Short (prior month Mar 15, 2024) 4339.93k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-45.94%

Management Effectiveness

Return on Assets (ttm)-36.40%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)8.23M
Revenue Per Share (ttm)0.13
Quarterly Revenue Growth (yoy)1,822.70%
Gross Profit (ttm)N/A
EBITDA -24.78M
Net Income Avi to Common (ttm)-32.48M
Diluted EPS (ttm)-0.5300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)28.92M
Total Cash Per Share (mrq)0.39
Total Debt (mrq)43M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.42
Book Value Per Share (mrq)-0.25

Cash Flow Statement

Operating Cash Flow (ttm)-18.14M
Levered Free Cash Flow (ttm)-17.93M